| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/11/2004 | US20040048321 Comprises (poly)peptides synthesized to match telopeptide components of type III collagen degradation products in body fluids; immunogens; antigens |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048312 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 03/11/2004 | US20040048307 Cell growth differentiation factors; for detecting increased muscle mass in food animals; kits |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048271 Fibroblast growth factor 11 |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048249 Novel nucleic acids and secreted polypeptides |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040048243 Identifying peptides by obtaining a sample, exposing it to a phage display library recovering bound substances; use in gene therapy vectors and in diagnosis and treatment of cancer |
| 03/11/2004 | US20040047923 Infiltrating with a buffer solution; vacuum environment; centrifuging and concentrating |
| 03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047878 DNA vaccine against feline immunodeficiency virus |
| 03/11/2004 | US20040047875 For use in diagnosis, prophylaxis and therapy |
| 03/11/2004 | US20040047862 Administering to mammal an effective amount of at least one monoclonal intravenous immunoglobulin (mIVIG) for a time and under conditions sufficient to increase the level of platelets |
| 03/11/2004 | US20040047861 For therapy and prophylaxis of thrombosis, in particular in inflammatory diseases, rejection of a transplant, transplant mediated arteriosclerosis, high blood pressures in kidney diseases, vessel restenosis after bypass surgery, stent |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047859 Reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell |
| 03/11/2004 | US20040047858 Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof |
| 03/11/2004 | US20040047856 Colorstrum-based composition |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047848 Induction of immunological tolerance |
| 03/11/2004 | CA2502636A1 Diagnosis of shwachman-diamond syndrome |
| 03/11/2004 | CA2497151A1 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | CA2497148A1 Tick polypeptides as anticoagulants and vaccines |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496795A1 Compositions and methods for treating cardiovascular disease |
| 03/11/2004 | CA2496626A1 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
| 03/11/2004 | CA2496523A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 03/11/2004 | CA2495833A1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 03/11/2004 | CA2495207A1 Modified transferin-antibody fusion proteins |
| 03/11/2004 | CA2494450A1 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 03/10/2004 | EP1396547A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/10/2004 | EP1396546A2 mycobacteria functional screening and/or expression vectors |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396539A1 Human-type anti-blood coagulation factor viii antibody |
| 03/10/2004 | EP1396501A1 Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 03/10/2004 | EP1396500A1 Anti-trail-r antibodies |
| 03/10/2004 | EP1395829A2 Cancer associated protein |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395610A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same |
| 03/10/2004 | EP1395609A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 03/10/2004 | EP1395608A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
| 03/10/2004 | EP1395275A2 Beta-secretase substrates and uses thereof |
| 03/10/2004 | EP1395274A2 Compositions and methods for inhibiting metastasis |
| 03/10/2004 | EP0769955B1 Non-antigenic amine derived polymers and polymer conjugates |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1480464A Ethane cyclic amp receptor protein of wheat and its coding sequence |
| 03/10/2004 | CN1141318C Human blood and blood vessel cytopoiesis hormone and its preparation |
| 03/09/2004 | US6703494 Thrombosis, adult respiratory system disorders |
| 03/09/2004 | US6703493 Ob (obesity) polypeptides possess an ability to participate in the control of mammalian body weight; use in detection, monitoring, screening, and diagnosis of modulators of weight control; use in treatment/regulation of obesity in mammals |
| 03/09/2004 | US6703488 Use for intracellular delivery of drugs or other agents for diagnosis and therapy of malignancies or immune-mediated or inflammatory conditions providing rapid, efficient internal-ization of the cytokine receptor antibody/antigen complexes |
| 03/09/2004 | US6703487 Polypeptide for use in the treatment of rheumatoid arthritis, myeloma, osteoporosis, endotoxemia, sepsis, osteoarthritis, inflammatory bowel disease and allergy |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703485 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 03/09/2004 | US6703360 Species-specific regions of nucleic acids that encode the heavy chain of canine immunoglobulin g and interleuken-13 receptors; regulation of immune and inflammatory responses |
| 03/09/2004 | US6703199 Fibronectin type iii (fn3) polypeptide monobody; phase display library |
| 03/09/2004 | US6703025 Multicomponent vaccines |
| 03/09/2004 | US6703020 Antibody conjugate methods for selectively inhibiting VEGF |
| 03/09/2004 | US6703018 Method of treatment using humanized anti-CD11a antibodies |
| 03/09/2004 | US6703015 Vaccination against plaque forming diseases, alzheimer's disease |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/04/2004 | WO2004018999A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 03/04/2004 | WO2004018997A2 Methods and compositions for modulating amyloid beta |
| 03/04/2004 | WO2004018683A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018679A1 Method and kit for diagnosing cancer |
| 03/04/2004 | WO2004018678A1 Preventives/remedies for cancer |
| 03/04/2004 | WO2004018670A1 Inhibitor of physiological activity of annexin 5 |
| 03/04/2004 | WO2004018660A2 Novel lipases and uses thereof |
| 03/04/2004 | WO2004018649A2 Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein |
| 03/04/2004 | WO2004018521A1 Anti-idiotype antibody, method of constructing the anti-idiotype antibody and method of preparing idiotype antibody using the anti-idiotype antibody |
| 03/04/2004 | WO2004018519A2 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 03/04/2004 | WO2004018518A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| 03/04/2004 | WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 03/04/2004 | WO2004018511A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | WO2004018510A1 Marker for cancer |
| 03/04/2004 | WO2004018505A1 Akap84 and its use for visualization of biological structures |
| 03/04/2004 | WO2004017992A2 Ptk7 protein involvement in carcinoma |
| 03/04/2004 | WO2004017991A1 Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin’s lymphomas |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017899A2 Mono-specific polyclonal antibodies and methods for detecting clostridium difficile toxin a |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004007538A3 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 03/04/2004 | WO2003106478A9 ANTIBODIES THAT BIND alphaE INTEGRIN |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |